Zomedica Corp.Largo
ZOM reaching denouement in symmetrical triangle
ZOM is about to reach the endpoint of it's symmetrical triangle. ZOM has been in the news a lot recently with the Carole Baskin mention and it also has a heavily patented technology coming out at the end of March. This stock has a great leadership team as well. Do you own do dill but I think this one is going up! Price target is $2.50.
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.